Emeriti Pharma AB
M├╢lndal · Founded 2014
About Emeriti Pharma AB
Emeriti Pharma AB develops a whole new treatment against skin disease rosacea. Today, rosacea is treated for a long time with different creams or antibiotic tablets. However, treatment is not so effective, it takes a long time to see results and the disease often returns after completion of treatment. Emeriti Pharma, a privately owned Swedish company, was founded in 2014 by former AstraZeneca scientists representing a wide knowledge of pharmaceutical research and development, often with many years in leading positions, and with experience of taking innovative drugs to the market.
Company Facts
- Founded: 2014
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Total funding: $230.2K
- Funding stage: Seed
- Last round: Seed (Nov 2015)
- Website: emeritipharma.se
- Phone: [email protected]
Canonical: https://fsome.com/organization/emeriti-pharma-ab-8313912 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.